• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

With Completion of Neovia Acquisition, ADM Creates Premier Global Leader in Animal Nutrition

Share:

February 4, 2019

Archer Daniels Midland Company announced today that it has successfully completed its €1.544 billion acquisition of Neovia, creating a global leader in value-added products and solutions for both production and companion animals.

“The addition of Neovia represents a major milestone in the execution of our strategic plan to become a global leader in nutrition,” said ADM Chairman and CEO Juan Luciano. “This acquisition — our largest since we added WILD Flavors in 2014 — instantly creates a premier global leader in animal nutrition, while simultaneously providing a strong platform for future growth. It meets our returns objectives, expands our geographic reach, and helps us continue to expand our portfolio and better serve our customers.”

ADM’s acquisition of WILD Flavors in 2014 kicked off the most extensive portfolio transformation in the company’s 115-year history, significantly expanding its human and animal nutrition capabilities. In the animal health and nutrition space, the company has made a series of expansions and investments in recent years, including:

  • Building and renovating three specialty animal nutrition plants in China and four plants in the U.S.;
  • Acquiring pet treat manufacturer Crosswind Industries;
  • Expanding pet food ingredient manufacturing capabilities in North America
  • Investing in state-of-the-art value added complete feed manufacturing facilities in North America
  • Entering into a partnership with China-based Qingdao Vland Biotech Group and building a cutting-edge research lab in California to develop and commercialize animal feed enzymes; and
  • Purchasing Protexin, a leading provider of probiotic supplements for human wellness as well as a variety of animal markets, including aquaculture, equine, livestock and companion animals.

Now, with the addition of Neovia, ADM Animal Nutrition spans the globe, offering premixes, complete feed, ingredients, pet care solutions, aquaculture, additives and amino acids to our customers.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“The acquisition of Neovia marks an important new chapter for ADM Animal Nutrition,” said Pierre Duprat, president, ADM Animal Nutrition. “I have been fortunate enough to meet with talented colleagues from Neovia over the last six months, and I am excited about the global platform this combination of our existing capabilities and Neovia has created to serve our customers and accelerate our growth. Combining our resources, expertise, innovation and research-driven technologies creates something very special: the premier global provider of animal nutrition ingredients and solutions, best-in-class customer service and leading R&D capabilities for our animal nutrition customers across the globe and creating value for our shareholders.”

Forward-Looking Statements

Some of the above statements constitute forward-looking statements. ADM’s filings with the SEC provide detailed information on such statements and risks, and should be consulted along with this release. To the extent permitted under applicable law, ADM assumes no obligation to update any forward-looking statements.

Date: February 4, 2019

Source: Business Journals

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Teladoc Health, Dexcom Offers CGM-Powered Insights to People with Type 2 DiabetesTeladoc Health, Dexcom Offers CGM-Powered Insights to People with Type 2 Diabetes
  • Lyra Health Completes $187M Series E Round and Expands User Base with ICAS WorldLyra Health Completes $187M Series E Round and Expands User Base with ICAS World
  • How Physicians Can Help Guide Patients Through Clinical TrialsHow Physicians Can Help Guide Patients Through Clinical Trials
  • Capital Rx Wins Top Award at Accenture HealthTech Innovation ChallengeCapital Rx Wins Top Award at Accenture HealthTech Innovation Challenge
  • Athira Pharma Closes $85 Million Series B FinancingAthira Pharma Closes $85 Million Series B Financing
  • Addressing Suggestibility as a Psychological Phenomenon in Clinical TrialsAddressing Suggestibility as a Psychological Phenomenon in Clinical Trials
  • Conversational AI Leader Announces Orbitaassist, a Digitally Reimagined Voice-Powered, AI-driven Virtual Health Assistant Proven to Improve Patient Communication at the BedsideConversational AI Leader Announces Orbitaassist, a Digitally Reimagined Voice-Powered, AI-driven Virtual Health Assistant Proven to Improve Patient Communication at the Bedside
  • Dr. Reddy’s Laboratories Announces the Acquisition of An Injectable Product Portfolio from Eton PharmaDr. Reddy’s Laboratories Announces the Acquisition of An Injectable Product Portfolio from Eton Pharma

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications